Best Wegovy Alternative for 2026? FDA Approves Oral Semaglutide as Patients Evaluate Compounded Telehealth Access — Direct Meds Examined as Verification Case Study

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Exercising more topped Americans' New Year's resolutions for 2026, with 25% of respondents listing it as their primary goal

  80% confidence

• Oral semaglutide 25 mg represents a significant advancement in obesity treatment

  80% confidence

• Approximately 12.4% of U.S. adults now report taking GLP-1 drugs for weight loss, more than double the 5.8% measured in February 2024

  80% confidence

• About half of adults who have taken GLP-1 drugs reported difficulty affording the cost

  80% confidence

• Compounded drugs should only be used when a patient's medical needs cannot be met by an FDA-approved medication

  80% confidence

• The agency is not aware of a basis for compounding using semaglutide sodium or semaglutide acetate salt forms

  80% confidence

• Approximately 48% of respondents ranked fitness goals as their highest priority heading into the new year

  80% confidence